Article Details
Retrieved on: 2021-12-19 13:14:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
20 December 2021, Sydney: AstraZeneca is pleased to welcome the reimbursement of Forxiga® (dapagliflozin) on the Pharmaceutical Benefits Scheme ...
Article found on: www.miragenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here